- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05255120
Hysterectomy - A Regional Intervention Study (HYSTERI)
The Effect of Systematic Preoperative Preparation on the Outcome of Benign Hysterectomy: a Prospective Intervention Study
Study Overview
Status
Intervention / Treatment
Detailed Description
Background Approximately 4,000 procedures with hysterectomy for benign indication are performed annually in Sweden. There are large differences between clinics in Sweden in the proportion of hysterectomies conducted using minimally invasive surgery. There is no uniformity in the planning of surgery. Patient-reported outcome measures, such as satisfaction and postoperatively unexpected symptoms, are important in assessing the outcome of surgery. Patient-reported measurements are, besides other factors, dependent on preoperative information. Mobile phone technology can possibly improve patient information and patient involvement.
Purpose
To evaluate whether a systematic preoperative preparation improves the outcome of elective hysterectomy on benign indication. The work consists of three parts with the following purposes:
Sub-study 1: To evaluate the effect of a preoperative algorithm for determining the most appropriate method of hysterectomy on the proportion undergoing surgery as a minimally invasive procedure and on the frequency of complications.
Sub-study 2: To compare patient-reported outcome measures, including unexpected symptoms, recovery, and satisfaction, in women who receive systematic preoperative information from specially trained staff and a mobile application with targeted education on the procedure, with women who receive information according to normal routines.
Sub-study 3: To investigate how women experience digitized information via a mobile application in connection with surgery.
Participating centers Departments of obstetrics and gynecology at the hospitals in Norrköping, Jönköping, Eksjö, Värnamo, Västervik, Kalmar and Växjö.
Schedule The study starts in September 2020. Recruitment of patients is planned to take two years.
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Preben Kjölhede, MD PhD
- Phone Number: +46101030000
- Email: preben.kjolhede@liu.se
Study Locations
-
-
-
Linköping, Sweden, 58185
- Recruiting
- University Hospital
-
Contact:
- Preben Kjölhede, Professor
- Phone Number: +46101030000
- Email: preben.kjolhede@liu.se
-
Norrköping, Sweden, 58185
- Recruiting
- Vrinnevisjukhuset
-
Contact:
- Lollo Makdessi Björklund, MD
- Phone Number: +46101030000
- Email: lollo.makdessi.bjorklund@regionostergotland.se
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Women 18 - 55 years old.
- Women undergoing hysterectomy for benign indication.
- Women with ASA 1 - 3.
- Women who understand and can express themselves in Swedish.
- Women who, by signing "Informed Consent", agree to participate in the study after written and oral information.
- Women who participate and respond to the surveys in the GynOp register.
- Women who have access to an I-phone, smartphone, computer or tablet and who can use the study-specific mobile application. (Does not apply to sub-study 1).
Exclusion criteria
- Women where both ovaries are removed during the operation.
- Women undergoing hysterectomy for prolapse indication.
- Women undergoing hysterectomy for cancer prophylactic indication.
- Women undergoing hysterectomy for gender reassignment purposes.
- Women with intellectual disabilities to such an extent that they can not fill in the relevant questionnaires etc. or if they do not understand the meaning of participating in the study or where there may be ethical doubts about the patient's participation in the study.
- Women who have a mental illness of such severity that the doctor in charge considers it inappropriate for the patient to be included in the study.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Intensified preoperative information
The patient participating in the intervention group is evaluated preoperatively based on an algorithm.
This information is designed according to a checklist which includes how the procedure is performed, rules of conduct in connection with and after the procedure and what the patient can expect after surgery.
|
The doctor takes a medical history and examines the patient according to regular routines, but uses the algorithm as support in deciding on the surgical method.
After the doctor's visit, the patient must see a research nurse to receive the intensified preoperative information about hysterectomy.
This information is designed according to a checklist.
The patient can also download a mobile application.
The study-specific mobile application (app) contains information about hysterectomy.
The information is structured in three parts - Before the Operation, At the Hospital and After the Operation.
A timeline describes the activities and events that occur before, around and after the operation.
Within each section there are several information links, with eg checklists.
|
No Intervention: Control group
The patient who participates in the control group receives information about participation in the study as a control, ie without information about the intervention.
The patient will then be planned for the procedure according to current, local routines.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Unexpected postoperative symtoms
Time Frame: Up to one year postoperatively
|
Proportion of patients with unexpected symptoms.
|
Up to one year postoperatively
|
Proportion minimally invasive hysterectomy
Time Frame: Retrospecive data 5 years before study start until completion of prospective study
|
Proportion of women undergoing hysterectomy as a minimally invasive procedure
|
Retrospecive data 5 years before study start until completion of prospective study
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Complication
Time Frame: Up to one year postoperatively
|
Numbers of and types of patient reported complications
|
Up to one year postoperatively
|
Lenght of stay
Time Frame: Day of surgery until discharge from hospital pre- and during the intervention
|
Hospital length of stay in connection with surgery
|
Day of surgery until discharge from hospital pre- and during the intervention
|
Sick leave
Time Frame: Day of discharge from hospital after surgery until return to normal work, maximal one year
|
return to work measured as actual sick leave length
|
Day of discharge from hospital after surgery until return to normal work, maximal one year
|
Recovery
Time Frame: Day of surgery until normal ADL, maximal one year
|
time to normal daily activity (ADL)
|
Day of surgery until normal ADL, maximal one year
|
Health related quality of life
Time Frame: Preoperatively up to one year postoperatively
|
Measured with EuroQol EQ-5D-3L health index comprising of two parts.
Part A Scale -0.5941 to 1.
A higher number indicates better quality of life.
Part B. EuroQol visual analoque scale EQ-VAS.
Scale 0-100.
A higher number indicates better quality of life
|
Preoperatively up to one year postoperatively
|
Collaborators and Investigators
Sponsor
Investigators
- Study Chair: Preben Kjölhede, MD PhD, University Hospital, Linköing
- Study Chair: Lollo Makdessi, MD, Vrinnevi Hospital, Norrköping
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- HYSTERI
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Benign Hysterectomy
-
Unity Health TorontoCompletedLaparoscopic Hysterectomy for Benign ConditionsCanada
-
Hospices Civils de LyonCompletedBenign Laparoscopic Hysterectomy | Systematic Salpingectomy
-
Istanbul UniversityUniversity of SurreyCompletedTotal Laparoscopic Hysterectomy | Benign ConditionsTurkey
-
Johns Hopkins UniversityCompletedRobotic Hysterectomy (Benign Indications/Early-stage Cancer)United States
-
Ethicon Endo-SurgeryCompletedBenign Disease Where Total Hysterectomy is IndicatedUnited States, Netherlands, United Kingdom
-
University Hospital, Strasbourg, FranceUnknownWomen Who Undergo a Laparoscopic Hysterectomy for Benign Disease.France
-
Minimally Invasive Devices, Inc.TerminatedCholecystectomy | Benign Hysterectomy | Salingo-oophorectomyUnited States
-
Hospital de Concentracion Norte de PetroleosCompletedAbdominal Hysterectomy for Benign DiseaseMexico
-
National Cancer Institute (NCI)CompletedHysterectomy | Oophorectomy for Benign ReasonsUnited States
-
Hanyang University Seoul HospitalCompletedHysterectomy, Benign Uterine Diseases
Clinical Trials on Intiensified structured perioperative information
-
University Hospital TuebingenCompletedStress | Age-related Macular DegenerationGermany
-
University Hospitals, LeicesterNational Institute for Health Research, United Kingdom; University of LeicesterCompleted
-
Martin-Luther-Universität Halle-WittenbergGerman Federal Ministry of Education and ResearchCompleted
-
Vidya RamanCompleted
-
Vastra Gotaland RegionGöteborg UniversityCompletedQuality of Life | Menopause | Mental Health | Women's Health | Primary Health Care | Sick LeaveSweden
-
VA Office of Research and DevelopmentNot yet recruiting
-
Vanderbilt UniversityCompletedPostoperative Nausea and VomitingUnited States
-
Vanderbilt University Medical CenterUMC UtrechtCompleted